Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib

Regorafenib has improved the survival of patients with refractory metastatic colorectal cancer (mCRC), yet the mechanisms of inherited or acquired resistance are not well understood. A total of 50 patients with refractory mCRC were enrolled. Circulating tumor cell (CTC) enumeration was carried out a...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsusaka, Satoshi, Hanna, Diana L., Ning, Yan, Yang, Dongyun, Cao, Shu, Berger, Martin D., Miyamoto, Yuji, Suenaga, Mitsukuni, Dan, Shingo, Mashima, Tetsuo, Seimiya, Hiroyuki, Zhang, Wu, Lenz, Heinz‐Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004533/
https://www.ncbi.nlm.nih.gov/pubmed/31821662
http://dx.doi.org/10.1111/cas.14273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004533/
https://www.ncbi.nlm.nih.gov/pubmed/31821662
http://dx.doi.org/10.1111/cas.14273

Ejemplares similares